BioCryst Pharmaceuticals
The Vice President, Biostatistics at BioCryst Pharmaceuticals leads the planning and delivery of statistical activities to support the design, conduct, and analysis of clinical studies. This role involves managing biostatistics staff, overseeing vendor relationships, and ensuring compliance with regulatory guidelines and Good Clinical Practice. The position requires strategic leadership in statistical methods, regulatory submissions, and the implementation of new processes to enhance productivity.
Headquarters
Durham, North Carolina, United States
Company Size
501-1000 employees
Founded
1986
BioCryst Pharmaceuticals is a global biotech company with over three decades of experience in drug discovery, development, and commercialization, specializing in rare disease therapeutics. Founded in 1986, the company focuses on hereditary angioedema (HAE) and other rare diseases, delivering first-in-class or best-in-class oral small-molecule and injectable protein therapeutics. BioCryst uses a novel, structure-guided approach blending traditional biology and medicinal chemistry with advanced technologies to develop medicines for underserved patient communities worldwide.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for BioCryst Pharmaceuticals.
BioCryst Pharmaceuticals didn’t post a salary, so this is our estimate from similar listings.